March 2020 – Varigen Biosciences has been selected to present its genome mining technologies for agricultural applications at the World Agri-Tech Innovation Summit in San Francisco, March 17-18, 2020.
June 2019 – Varigen Biosciences will present “New Tools for Targeted Cloning and Over Expression of Biosynthetic Gene Clusters” at the 2nd Synthetic Biology For Natural Products Conference.
May 2019 – Varigen Biosciences will present “New Tools for Targeted Cloning and Over Expression of Biosynthetic Gene Clusters” at the Copenhagen Bioscience Conference 16 – Natural Products: Discovery, Biosynthesis and Application.
September 2018 – Varigen Biosciences will give a talk entitled “Gel Free Targeted Cloning of Large Biosynthetic Gene Clusters” at the 3rd European Conference on Natural Products.
August 2018 – Varigen Biosciences will give a talk entitled “Mining and Expressing Biosynthetic Gene Clusters from Soil Metagenomes,” at the SIMB Annual Meeting 2018.
July 2018 – Varigen Biosciences is awarded a National Institutes of Health SBIR Phase I grant to enable capture of intact, long DNA from complex samples.
July 2017 – Varigen Biosciences certified by State of Wisconsin as a Qualified New Business Venture.
May 2017 – Varigen Biosciences is awarded a National Institutes of Health SBIR grant to enable cloning of complex and large DNAs, such as biosynthetic gene clusters.
March 2017 – Dr. David Mead, CEO of Varigen Biosciences, co-organizes Synthetic Biology for Natural Products meeting.
January 2017 – Varigen Biosciences is awarded a National Science Foundation SBIR grant to enable amplification of biosynthetic gene clusters and other large DNAs.
505 S. Rosa Road
Madison, WI 53719
Varigen Biosciences Corporation is an NIH- and NSF-funded effort to harness naturally occurring microbial diversity to develop the next generation of natural products through genomics and metagenomics. Varigen's team is led by researchers with over 125 years of combined experience.